News|Articles|August 29, 2023
Gene Therapy Development: Pathway to Commercialization
Author(s)Pace Analytical Life Sciences
Oligonucleotides are a class of biotherapeutics presenting complex challenges in the development and commercialization of gene therapies. Download our paper and learn how to move your project forward.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
What to Know from the FDA’s End of August Activity
2
Pharma's Next AI Problem Is Authority
3
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
4
Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines
5